Marketwire - Dublin, Ireland, 9 September 2008 - AGI Therapeutics plc (“AGI” or the"Company”) (AIM, IEX: AGI), a speciality pharmaceutical development company focused on gastrointestinal drug products, today reports interim financial results for the six months ended 30 June 2008.
